This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilkinson, J. C.
Right arrow Articles by Duckett, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilkinson, J. C.
Right arrow Articles by Duckett, C. S.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, August 2004, p. 7003-7014, Vol. 24, No. 16
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.16.7003-7014.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Upstream Regulatory Role for XIAP in Receptor-Mediated Apoptosis{dagger}

John C. Wilkinson,1 Enrique Cepero,2 Lawrence H. Boise,2 and Colin S. Duckett1,3*

Departments of Pathology,1 Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109,3 Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, Florida 331012

Received 19 December 2003/ Returned for modification 27 February 2004/ Accepted 26 April 2004

X-linked inhibitor of apoptosis (XIAP) is an endogenous inhibitor of cell death that functions by suppressing caspases 3, 7, and 9. Here we describe the establishment of Jurkat-derived cell lines stably overexpressing either full-length XIAP or a truncation mutant of XIAP that can only inhibit caspase 9. Characterization of these cell lines revealed that following CD95 activation full-length XIAP supported both short- and long-term survival as well as proliferative capacity, in contrast to the truncation mutant but similar to Bcl-xL. Full-length XIAP was also able to inhibit CD95-mediated caspase 3 processing and activation, the mitochondrial release of cytochrome c and Smac/DIABLO, and the loss of mitochondrial membrane potential, whereas the XIAP truncation mutant failed to prevent any of these cell death events. Finally, suppression of XIAP levels by RNA interference sensitized Bcl-xL-overexpressing cells to death receptor-induced apoptosis. These data demonstrate for the first time that full-length XIAP inhibits caspase activation required for mitochondrial amplification of death receptor signals and that, by acting upstream of mitochondrial activation, XIAP supports the long-term proliferative capacity of cells following CD95 stimulation.

* Corresponding author. Mailing address: Med Sci I, Room 5315, 1301 Catherine, Ann Arbor, MI 48109-0602. Phone: (734) 615-6414. Fax: (734) 615-7012. E-mail: colind{at}umich.edu.

{dagger} Supplemental material for this article may be found at http://mcb.asm.org/.

Molecular and Cellular Biology, August 2004, p. 7003-7014, Vol. 24, No. 16
0022-538X/04/$08.00+0     DOI: 10.1128/MCB.24.16.7003-7014.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Dean, E., Jodrell, D., Connolly, K., Danson, S., Jolivet, J., Durkin, J., Morris, S., Jowle, D., Ward, T., Cummings, J., Dickinson, G., Aarons, L., LaCasse, E., Robson, L., Dive, C., Ranson, M. (2009). Phase I Trial of AEG35156 Administered as a 7-Day and 3-Day Continuous Intravenous Infusion in Patients With Advanced Refractory Cancer. JCO 27: 1660-1666 [Abstract] [Full Text]  
  • Fakler, M., Loeder, S., Vogler, M., Schneider, K., Jeremias, I., Debatin, K.-M., Fulda, S. (2009). Small molecule XIAP inhibitors cooperate with TRAIL to induce apoptosis in childhood acute leukemia cells and overcome Bcl-2-mediated resistance. Blood 113: 1710-1722 [Abstract] [Full Text]  
  • Shawgo, M. E., Shelton, S. N., Robertson, J. D. (2008). Caspase-mediated Bak Activation and Cytochrome c Release during Intrinsic Apoptotic Cell Death in Jurkat Cells. J. Biol. Chem. 283: 35532-35538 [Abstract] [Full Text]  
  • Lu, J., Bai, L., Sun, H., Nikolovska-Coleska, Z., McEachern, D., Qiu, S., Miller, R. S., Yi, H., Shangary, S., Sun, Y., Meagher, J. L., Stuckey, J. A., Wang, S. (2008). SM-164: A Novel, Bivalent Smac Mimetic That Induces Apoptosis and Tumor Regression by Concurrent Removal of the Blockade of cIAP-1/2 and XIAP. Cancer Res. 68: 9384-9393 [Abstract] [Full Text]  
  • Milleron, R. S., Bratton, S. B. (2006). Heat Shock Induces Apoptosis Independently of Any Known Initiator Caspase-activating Complex. J. Biol. Chem. 281: 16991-17000 [Abstract] [Full Text]  
  • Kater, A. P., Dicker, F., Mangiola, M., Welsh, K., Houghten, R., Ostresh, J., Nefzi, A., Reed, J. C., Pinilla, C., Kipps, T. J. (2005). Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis. Blood 106: 1742-1748 [Abstract] [Full Text]  
  • Fernandez, Y., Verhaegen, M., Miller, T. P., Rush, J. L., Steiner, P., Opipari, A. W. Jr., Lowe, S. W., Soengas, M. S. (2005). Differential Regulation of Noxa in Normal Melanocytes and Melanoma Cells by Proteasome Inhibition: Therapeutic Implications. Cancer Res. 65: 6294-6304 [Abstract] [Full Text]  
  • Samuel, T., Okada, K., Hyer, M., Welsh, K., Zapata, J. M., Reed, J. C. (2005). cIAP1 Localizes to the Nuclear Compartment and Modulates the Cell Cycle. Cancer Res. 65: 210-218 [Abstract] [Full Text]  
  • Wilkinson, J. C., Richter, B. W. M., Wilkinson, A. S., Burstein, E., Rumble, J. M., Balliu, B., Duckett, C. S. (2004). VIAF, a Conserved Inhibitor of Apoptosis (IAP)-interacting Factor That Modulates Caspase Activation. J. Biol. Chem. 279: 51091-51099 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»